A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status.
Raveena RavikumarTristan Robert Alexander LaneAdarsh BabberSarah OnidaAlun Huw DaviesPublished in: Phlebology (2020)
Daily NMES usage increases flow parameters, with twice daily usage improving QoL and clinical severity at 6 weeks in CVD patients.